NRC Health Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
NRC Health (NRC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 370.70 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-06
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 370.70K shares, a 13.36% decline year-over-year.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 553.25K shares, a 37.34% increase year-over-year.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 403.14K shares, a 2.88% increase year-over-year.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 427.84K shares, a 57.48% increase year-over-year.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for fiscal 2012 was 30.82K shares, a 74.22% decline from fiscal 2011.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for fiscal 2011 was 119.57K shares, a 68.92% decline from fiscal 2010.
- NRC Health antidilutive securities excluded from computation of earnings per share, amount for fiscal 2010 was 384.65K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | 370.70K shares 10-Q · filed 2026-05-06 | |||||
| 2025-09-30 | 553.25K shares 10-Q · filed 2025-11-07 | 415.70K shares 10-Q · filed 2025-11-07 | ||||
| 2025-06-30 | 403.14K shares 10-Q · filed 2025-08-08 | 434.52K shares 10-Q · filed 2025-08-08 | ||||
| 2025-03-31 | 427.84K shares 10-Q · filed 2026-05-06 | |||||
| 2024-09-30 | 402.82K shares 10-Q · filed 2025-11-07 | 406.71K shares 10-Q · filed 2025-11-07 | ||||
| 2024-06-30 | 391.86K shares 10-Q · filed 2025-08-08 | 796.69K shares 10-Q · filed 2024-08-08 | 309.63K shares 10-Q · filed 2025-08-08 | 674.43K shares 10-Q · filed 2024-08-08 | ||
| 2024-03-31 | 271.67K shares 10-Q · filed 2025-05-09 | 596.43K shares 10-Q · filed 2024-05-09 | ||||
| 2023-09-30 | 275.06K shares 10-Q · filed 2024-11-08 | 268.84K shares 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | 276.95K shares 10-Q · filed 2024-08-08 | 265.67K shares 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | 254.27K shares 10-Q · filed 2024-05-09 | |||||
| 2022-09-30 | 343.41K shares 10-Q · filed 2023-11-09 | 306.45K shares 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 305.99K shares 10-Q · filed 2023-08-04 | 287.65K shares 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | 231.32K shares 10-Q · filed 2023-05-05 | |||||
| 2021-09-30 | 145.74K shares 10-Q · filed 2022-11-04 | 122.17K shares 10-Q · filed 2022-11-04 | ||||
| 2021-06-30 | 103.70K shares 10-Q · filed 2022-08-05 | 108.34K shares 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | 109.29K shares 10-Q · filed 2022-05-06 | |||||
| 2013-03-31 | 27.48K shares 10-Q · filed 2013-05-08 | |||||
| 2012-12-31 | 30.82K shares 10-K · filed 2013-03-01 | |||||
| 2012-03-31 | 80.24K shares 10-Q · filed 2013-05-08 | |||||
| 2011-12-31 | 119.57K shares 10-K · filed 2013-03-01 | |||||
| 2011-06-30 | 82.19K shares 10-Q · filed 2012-08-10 | |||||
| 2010-12-31 | 384.65K shares 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |